AstraZeneca and Bristol Myers discuss potential merger
AstraZeneca (NASDAQ:AZN) has reportedly engaged in early-stage negotiations regarding a potential merger with Bristol Myers Squibb (NYSE:BMY).
AstraZeneca (NASDAQ:AZN) has reportedly engaged in early-stage negotiations regarding a potential merger with Bristol Myers Squibb (NYSE:BMY).
Sportradar (NASDAQ:SRAD) reported Q2 revenue of €378 million, up 19%, while adjusted EBITDA increased 19% to €76 million.
Ocular Therapeutix (NASDAQ:OCUL) reported Q2 revenue of $13.5 million and plans a Q4 AXPAXLI filing after FDA alignment.
IBM Vice Chairman Gary Cohn says, "the market became addicted to knowing what the Fed was going to do" as he discusses market reaction to Federal Reserve Chairman Kevin Warsh's handling of the US central bank. Cohn also discusses Japan and the US Treasury Department working together to shore up the yen and the instabilities being dealt with by markets. He speaks on "Bloomberg Surveillance."
Krystal Biotech (NASDAQ:KRYS) reported Q2 VYJUVEK revenue of $119.2 million, up 24%, and net income of $54.8 million.
Hess Midstream (NYSE:HESM) reported Q2 revenue of $399 million, net income of $173.7 million and adjusted free cash flow of $231.6 million.
IBM Vice Chairman Gary Cohn says, "the market became addicted to knowing what the Fed was going to do" as he discusses market reaction to Federal Reserve Chairman Kevin Warsh's handling of the US central bank. He speaks on "Bloomberg Surveillance."
Compugen (NASDAQ:CGEN) reported Q2 revenue of $2.6 million and said its $125.3 million cash position could fund operations into 2029.
Tyson Foods (NYSE:TSN) announced its financial results for the fiscal third quarter of 2026, reporting flat sales of $13.87 billion.
Lindblad Expeditions Holdings (NASDAQ:LIND) reported Q2 tour revenue of $199.2 million, up 19% year over year.
Rebecca Walser of Walser Wealth Management joins Vonnie Quinn on "Bloomberg Brief" to discuss the implications of Fed Chair Kevin Warsh mulling changes to the frequency and timing of the Fed's policy meetings.
Marriott International (NASDAQ:MAR) announced its second-quarter 2026 financial results, reporting an adjusted net income of $844 million.